Table 3.
Clinical significance of the Hemophilia Activities List (HAL) and Hemophilia Joint Health Score (HJHS) in patients with severe hemophilia A before and after prophylaxis, and quality of life (QoL) in patients with severe hemophilia A before and after prophylaxis, from a single institution
| Before prophylaxis | After prophylaxis | p-value | |
|---|---|---|---|
| Hemophilia Activities List (HAL), mean (SE) | |||
| Age > 18 years (n = 27) | 78.06 (4.39) | 79.59 (3.93) | 0.735 |
| Age ≤ 18 years (n = 6) | 79.82 (4.75) | 98.57 (0.55) | 0.021* |
| Hemophilia Joint Health Score (HJHS) | |||
| Age > 18 years (n = 27) | 37.15 (4.12) | 33.27 (4.13) | 0.681 |
| Age ≤ 18 years (n = 6) | 5.40 (1.99) | 5.00 (0.11) | 0.410 |
| Quality of life (QoL) | |||
| A single institution (n = 18) | 38.88 (3.64) | 23.24 (2.45) | 0.036* |
* p < 0.05